These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 9444402)

  • 1. Detection of fluoroquinolones in urinary specimens from patients undergoing anti-tuberculous therapy.
    Chan CY; Tsang DS; Chan TL; Yew WW; Cheung SW; Cheng AF
    Chemotherapy; 1998; 44(1):7-11. PubMed ID: 9444402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New fluoroquinolone antibiotics.
    Drug Ther Bull; 1999 Jan; 37(1):6-8. PubMed ID: 10562769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharma-clinics. The drug of the month. Levofloxacin (Tavanic)].
    Scheen AJ
    Rev Med Liege; 2000 Nov; 55(11):1015-7. PubMed ID: 11195704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.
    Tomii Y; Ozaki M; Matsuda M; Honmura T; Nishimura I; Yamaguchi R; Adachi T; Okawa Y; Nishino T
    Arzneimittelforschung; 1996 Dec; 46(12):1169-73. PubMed ID: 9006794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levofloxacin and sparfloxacin: new quinolone antibiotics.
    Martin SJ; Meyer JM; Chuck SK; Jung R; Messick CR; Pendland SL
    Ann Pharmacother; 1998 Mar; 32(3):320-36. PubMed ID: 9533064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary concentrations and bactericidal activities of newer fluoroquinolones in healthy volunteers.
    Stein GE; Schooley S
    Int J Antimicrob Agents; 2004 Aug; 24(2):168-72. PubMed ID: 15288316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic drug monitoring of fluoroquinolone].
    Matsumoto F; Takahashi T; Morita M
    Nihon Rinsho; 1990 Feb; 48 Suppl():1217-22. PubMed ID: 2355524
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro activity of enoxacin versus ciprofloxacin, fleroxacin, lomefloxacin, ofloxacin, pefloxacin, and rufloxacin against uropathogens.
    Naber KG; Well M; Hollauer K; Kirchbauer D; Witte W
    Chemotherapy; 1998; 44(2):77-84. PubMed ID: 9551236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levofloxacin, a second-generation fluoroquinolone.
    North DS; Fish DN; Redington JJ
    Pharmacotherapy; 1998; 18(5):915-35. PubMed ID: 9758306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose.
    Wagenlehner FM; Kinzig-Schippers M; Tischmeyer U; Wagenlehner C; Sörgel F; Dalhoff A; Naber KG
    Int J Antimicrob Agents; 2006 Jan; 27(1):7-14. PubMed ID: 16343856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New chemiluminescent method of levofloxacin and ofloxacin determination based on terbium (III)-sensitized fluoroquinolone-KBrO
    Kaczmarek M; Staninski K; Stodolny M
    Luminescence; 2021 Dec; 36(8):1945-1952. PubMed ID: 34323366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfer of ciprofloxacin, ofloxacin and levofloxacin across the perfused human placenta in vitro.
    Polachek H; Holcberg G; Sapir G; Tsadkin-Tamir M; Polachek J; Katz M; Ben-Zvi Z
    Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):61-5. PubMed ID: 16154040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of side effects of levofloxacin versus other fluoroquinolones.
    Carbon C
    Chemotherapy; 2001; 47 Suppl 3():9-14; discussion 44-8. PubMed ID: 11549784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the minimum inhibitory, mutant prevention and minimum bactericidal concentrations of ciprofloxacin, levofloxacin and garenoxacin against enteric Gram-negative urinary tract infection pathogens.
    Hansen GT; Blondeau JM
    J Chemother; 2005 Oct; 17(5):484-92. PubMed ID: 16323436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro antibacterial activity of trovafloxacin and five other fluoroquinolones.
    Montanari MP; Prenna M; Mingoia M; Ripa S; Varaldo PE
    Chemotherapy; 1998; 44(2):85-93. PubMed ID: 9551237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentrations in plasma, urinary excretion and bactericidal activity of levofloxacin (500 mg) versus ciprofloxacin (500 mg) in healthy volunteers receiving a single oral dose.
    Wagenlehner FM; Kinzig-Schippers M; Sörgel F; Weidner W; Naber KG
    Int J Antimicrob Agents; 2006 Dec; 28(6):551-9. PubMed ID: 17101261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct determination of four fluoroquinolones, enoxacin, norfloxacin, ofloxacin, and ciprofloxacin, in pharmaceuticals and blood serum by HPLC.
    Samanidou VF; Demetriou CE; Papadoyannis IN
    Anal Bioanal Chem; 2003 Mar; 375(5):623-9. PubMed ID: 12638045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. False-positive EMIT II opiates from ofloxacin.
    Meatherall R; Dai J
    Ther Drug Monit; 1997 Feb; 19(1):98-9. PubMed ID: 9029757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPLC determination of enoxacin, ciprofloxacin, norfloxacin and ofloxacin with photoinduced fluorimetric (PIF) detection and multiemission scanning: application to urine and serum.
    Espinosa-Mansilla A; Peña AM; Gómez DG; Salinas F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Aug; 822(1-2):185-93. PubMed ID: 16006203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a lateral flow immunoassay strip for screening of sulfamonomethoxine residues.
    Zhang G; Wang X; Zhi A; Bao Y; Yang Y; Qu M; Luo J; Li Q; Guo J; Wang Z; Yang J; Xing G; Chai S; Shi T; Liu Q
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2008 Apr; 25(4):413-23. PubMed ID: 18348040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.